More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia

Blood. 2017 May 4;129(18):2584-2587. doi: 10.1182/blood-2016-11-749903. Epub 2017 Feb 28.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Humans
  • Leukemia, Erythroblastic, Acute* / drug therapy
  • Leukemia, Erythroblastic, Acute* / genetics
  • Leukemia, Erythroblastic, Acute* / mortality
  • Male
  • Middle Aged
  • Mutation*
  • Retrospective Studies
  • Survival Rate
  • Tumor Suppressor Protein p53 / genetics*

Substances

  • TP53 protein, human
  • Tumor Suppressor Protein p53